TP53 and breast cancer: Collectively, these findings delineate an apoptosis-dependent pathway whereby chemotherapeutic stress initiates mitochondrial apoptosis, activates the ARTS–Livin–MDM2–p53 axis, and drives prosurvival autophagy, ultimately fostering breast cancer chemoresistance.